Dr. Reddys Labs (RDY) Tops Q4 EPS by 10c

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $867 million versus the consensus estimate of $833.44 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Exclusive: Axe Compute CEO says prepayments cover about a third of $3bn build cost
• Array Technologies acquires wire management firm Affordable Wire Management